EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional Analysis of Human GBA1 Missense Mutations in Drosophila: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences

Aparna Kuppuramalingam iD, Or Cabasso, Mia Horowitz iD

Cells · 2024

DOI: 10.3390/cells13191619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Aparna Kuppuramalingam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel. Hauptthemen laut MEDLINE: Gaucher Disease, Glucosylceramidase, Mutation, Missense, Phenotype. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human GBA1 gene encodes lysosomal acid β-glucocerebrosidase, whose activity is deficient in Gaucher disease (GD). In Drosophila, there are two GBA1 orthologs, Gba1a and Gba1b, and Gba1b is the bona fide GCase encoding gene. Several fly lines with different deletions in the Gba1b were studied in the past. However, since most GD-associated GBA1 mutations are point mutations, we created missense mutations homologous to the two most common GD mutations: the mild N370S mutation (D415S in Drosophila) and the severe L444P mutation (L494P in Drosophila), using the CRISPR-Cas9 technology. Flies homozygous for the D415S mutation (dubbed D370S hereafter) presented low GCase activity and substrate accumulation, which led to lysosomal defects, activation of the Unfolded Protein Response (UPR), inflammation/neuroinflammation, and neurodegeneration along with earlier death compared to control flies. Surprisingly, the L494P (called L444P hereafter) flies presented higher GCase activity with fewer lysosomal defects and milder disease in comparison to that presented by the D370S homozygous flies. Treatment with ambroxol had a limited effect on all homozygous fly lines tested. Overall, our results underscore the differences between the fly and human GCase enzymes, as evidenced by the distinct phenotypic outcomes of mutations in flies compared to those observed in human GD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gaucher DiseaseGlucosylceramidaseMutation, MissensePhenotypeLysosomesAnimalsHumansDrosophila melanogasterDisease Models, AnimalUnfolded Protein ResponseDrosophila

Stichwörter der Autor:innen

DrosophilaGBA1Gaucher diseaseacid-β-glucocerebrosidaseambroxolglucosylceramide

Substanzen

GlucosylceramidaseGBA protein, human

Autor:innen und Institutionen

  • Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
  • Sagol School of Neuroscience, Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.

ORCID-Profile: Aparna Kuppuramalingam, Mia Horowitz

Förderung

  • Israel science Foundation

Zitieren

APA

Kuppuramalingam, A., Cabasso, O., & Horowitz, M. (2024). Functional Analysis of Human GBA1 Missense Mutations in Drosophila: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences. Cells. https://doi.org/10.3390/cells13191619

Vancouver

Kuppuramalingam A, Cabasso O, Horowitz M. Functional Analysis of Human GBA1 Missense Mutations in Drosophila: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences. Cells. 2024. doi:10.3390/cells13191619

BibTeX
@article{Kuppuramalingam2024,
  author = {Kuppuramalingam, Aparna and Cabasso, Or and Horowitz, Mia},
  title = {Functional Analysis of Human GBA1 Missense Mutations in Drosophila: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13191619}
}
Kostenlos starten →